Q2 2025 Diagnosticos da America SA Earnings Call Transcript
Key Points
- Diagnosticos da America SA (BSP:DASA3) successfully closed a joint venture with Amil hospitals, creating one of the largest healthcare groups in Brazil.
- The company reported a significant reduction in net debt by BRL3.4 billion, ending the quarter at BRL7.3 billion.
- EBITDA grew by 8% with an expansion in gross margin, reflecting operational excellence and productivity improvements.
- The company maintained a positive cash generation of BRL44 million, with a reduction in the cash cycle by six days.
- The diagnostic sector saw a 6% increase in gross revenue, driven by a 4% increase in exams and a 2% rise in the average ticket.
- The international division, particularly in Argentina, was negatively impacted by exchange rate fluctuations.
- Gross revenue for the oncology segment in the Northeast dropped by 3% due to the interruption of underperforming operations.
- SG&A expenses increased by 7% due to provisions for doubtful accounts, despite a reduction from deconsolidation impacts.
- The company faces challenges in further reducing leverage, with current levels close to 4x EBITDA.
- Rede Americas, the new joint venture, started with a certain level of leverage, impacting financial results.
Good afternoon, ladies and gentlemen. Welcome to conference call to discuss the results for the second-quarter '25. This conference call is being recorded, and the replay will be available on the company's website www.dasa3.com.br. The presentation will also be available for download. (Operator Instructions)
Please bear in mind that the information contained in this presentation as well as any statements may be made during this event regarding DASA's business outlook -- projections and operational and financial targets constitute the beliefs and assumptions of the company's management as well as currently available information. Forward-looking statements are no guarantee of performance may involve risks, uncertainties, and assumptions as they refer to future events. And they depend on circumstances that may or may not occur. Investor should understand that overall economic conditions, market conditions, and other operational factors may affect DASA's future performance.
I will now turn the floor over to Mr. Licio Cintra, we
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
